Key Insights

Highlights

Success Rate

86% trial completion

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 52/100

Termination Rate

5.1%

3 terminated out of 59 trials

Success Rate

86.4%

-0.2% vs benchmark

Late-Stage Pipeline

12%

7 trials in Phase 3/4

Results Transparency

16%

3 of 19 completed with results

Key Signals

3 with results86% success

Data Visualizations

Phase Distribution

26Total
Not Applicable (16)
P 1 (2)
P 2 (1)
P 3 (3)
P 4 (4)

Trial Status

Completed19
Recruiting17
Unknown13
Terminated3
Active Not Recruiting2
Enrolling By Invitation2

Trial Success Rate

86.4%

Benchmark: 86.5%

Based on 19 completed trials

Clinical Trials (59)

Showing 20 of 20 trials
NCT05863676Active Not RecruitingPrimary

Ovarian Tissue Cryopreservation in the Setting of Gender-affirming Therapy

NCT05829928Active Not RecruitingPrimary

Testicular Tissue Cryopreservation in the Setting of Gender-Affirming Therapy

NCT04309760Not ApplicableWithdrawnPrimary

Developmental Correlates and Hormone Therapy Effects in Gender Dysphoria

NCT07147166Not ApplicableRecruitingPrimary

Evaluating the Efficacy of Force Modulating Tissue Bridge Device in Preventing Hypertrophic Scars Following Gender-Affirming Mastectomy

NCT07624747RecruitingPrimary

Brain Health in Transgender Adults

NCT05273112Not Yet RecruitingPrimary

Evaluation of the Variation in Quality of Life During Medical Transition for Transgender People.

NCT06565663Not ApplicableEnrolling By InvitationPrimary

MaPGAS Decision Making

NCT06615401CompletedPrimary

Understanding Perceived Access and Receipt of Gender-affirming Treatments Among Transgender Veterans

NCT05897086Phase 2Enrolling By InvitationPrimary

Polyethylene-glycol Assisted Nerve Repair in Phalloplasty

NCT06245681RecruitingPrimary

Effects of Cross-sex Hormone Treatment on Cardiac Function, Myocardial and Hepatic Fat Content

NCT06291675RecruitingPrimary

Gender-Affirming Hormone Therapy and Its Impact on Myocardial Mass and Cardiac Function, Heart, Liver and Pancreatic Fat Content

NCT04979338Phase 3RecruitingPrimary

Development of Effective, Opioid Sparing Techniques for Peri-operative Pain Management of Transgender Patients Undergoing Gender Affirming Surgeries

NCT06022562CompletedPrimary

Effects of Gender-affirming Hormone Therapy on Transgender People

NCT05166083CompletedPrimary

Investigation of the Perceptual and Acoustic Voice in Trans Man

NCT04596592Recruiting

Pubertal Blockade and Estradiol Effects on Cardiometabolic Health for Transitioning Youth

NCT05903911Not ApplicableCompletedPrimary

Trans Care: An Online Intervention to Reduce Symptoms of Gender Dysphoria

NCT06969326Phase 3Recruiting

Topical Estrogen: Brief Intervention to Improve Postoperative Experience for Transgender Men Undergoing Hysterectomy

NCT05204732Not ApplicableCompletedPrimary

Acoustic and Perceptual Effects of Intonation Training in Gender Diverse People

NCT04283656Phase 1Completed

Evaluating Drug Interactions Between Doravirine With Estradiol and Spironolactone in Healthy Transgender Women

NCT06351501Phase 3RecruitingPrimary

Evaluation of the Effectiveness of Hormonal Treatment in Adolescents Suffering from Gender Dysphoria

Scroll to load more

Research Network

Activity Timeline